The World’s Leading
NON-INVASIVE
FETAL TRISOMY
TEST
OVER 13,700,000 TESTED WORLDWIDE. GUARANTEED WITH CONFIDENCE.
Expecting Parents
Healthcare Providers
Up to RMB400,000 coverage.
Diagnosis benefit for high risk results.
Refund protection for no result report.
Up to RMB400,000 coverage. Diagnosis benefit for high risk results. Refund protection for no result report.
- Introducing NIFTY®
NIFTY® (Non-Invasive Fetal TrisomY test) is a safe, simple, non-invasive prenatal test (or NIPT), which offers screening for certain genetic conditions from as early as week 10 of pregnancy. Using the latest genetic sequencing technology, NIFTY® has over >99% accuracy for the three most common trisomy conditions present at birth, which are Down Syndrome, Edwards Syndrome and Patau Syndrome. To find out more about the test, please click on the link below.
- The Advantages of The NIFTY® Test
Reliable
Up to 99% high sensitivity and specificity[5], tested by a Hong Kong laboratory and reported by a registered Class I medical laboratory in Hong Kong.
Safe
Non-invasive with no risk of miscarriage
Simple
Only 6-10mL of intravenous blood from a pregnant woman is required for the test.
Comprehensive
Detection of 22 types of chromosomal trisomy, 4 types of sex chromosome abnormalities, 84 types of chromosomal microdeletion duplication syndrome, and sex of fetus.
Fast
Reports are issued within 5-7 working days to help physicians make rapid clinical decisions.
Reliable
Up to 99% high sensitivity and specificity[5], tested by a Hong Kong laboratory and reported by a registered Class I medical laboratory in Hong Kong.
Safe
Non-invasive with no risk of miscarriage
Simple
Only 6-10mL of intravenous blood from a pregnant woman is required for the test.
Comprehensive
Detection of 22 types of chromosomal trisomy, 4 types of sex chromosome abnormalities, 84 types of chromosomal microdeletion duplication syndrome, and sex of fetus.
Fast
Reports are issued within 5-7 working days to help physicians make rapid clinical decisions.
Technology
- Blood sampling is safe and convenient.
- High-throughput sequencing technology for 95+18 tests+Additional findings.
- High-quality standard to monitor the free DNA concentration of compensated children.
- Clinical data validation for twins.
International Certification
- International patented gene analysis method PCT/CN2011/ 001070.
- More than 50 international medical papers validation support.
- NIFTY® Test Video
- Service Process
Only 6-10mL of intravenous blood is required for collection by a medical professional.
Samples will send to the Hong Kong Laboratory for DNA analysis (DNA of the fetus in the mother’s blood).
The report will be available in 5-7 working days.
The health of your child is the most important concern of every parent!
Enquire Form
